Start Date
December 31, 2020
Primary Completion Date
December 31, 2020
Study Completion Date
December 31, 2020
rejuvesol Solution
The rejuvenation process involves incubation of stored red cells with a rejuvenating solution, rejuvesol Red Blood Cell Processing Solution (rejuvesol® Solution), Citra labs, MA, a Zimmer Biomet Company, IN, USA) which restores red cell adenosine triphosphate (ATP), 2,3-DPG (diphosphoglycerate), oxygen transfer characteristics and rheology. Post rejuvenation red cells are washed to remove the rejuvesol Solution, and cells are re-suspended in additive solution for transfusion.
Standard Care
Allogeneic red cells, harvested in citrate-phosphate-dextrose (CPD), leucocyte depleted, saline-adenine-glucose-mannitol (SAGM) stored red cell units, issued by National Health Service Blood \& Transplant (NHSBT) will be administered to cardiac surgery patients as per standard practice, and according to established unit protocols.
Department of Cardiovascular Sciences, Leicester
Collaborators (1)
National Health Service, United Kingdom
OTHER_GOV
Zimmer Biomet
INDUSTRY
British Heart Foundation
OTHER
University of Leicester
OTHER